Government Aided Pharmacy College Permanently Affiliated To University Of Mumbai, Approved By AICTE DTE And PCI, NBA Accreditation For 2008-2013,

Only Pharmacy Institute in INDIA rated as Best Industry Linked under Mentor category by AICTE-CII

MISSION

To educate and train students in the knowledge and practice of pharmaceutical sciences and to contribute to improvement of health of the society, through education and research programs.

VISION

To be a leader in Pharmacy Education, Pharmacy Training, and Research in Pharmaceutical Sciences.

Faculty of Pharmaceutics Department

Name of the Faculty: Dr. (Mrs.) M. S. Nagarsenker

Designation: Professor and HOD, Pharmaceutics

Email: mangal.nagarsenker@gmail.com

Teaching Fields : Pharmaceutics, novel drug delivery systems, dispensing pharmacy, physical pharmacy.





Educational Qualifications:

Sr no. Degree University Year of Passing
1) B. Pharm. Mumbai University 1978
2) M. Pharm. Mumbai University 1981
3) Ph.D. (Tech.) Mumbai University 1989

Awards and Fellowships:

Sr no. Award/Fellowship Year of Receipt
1) Dr. K.G. Nair Award (first prize) for Preclinical poster presentation titled on “Pulmonary delivery of Fluoroquinolone antibiotic complemented with Proteolytic enzyme in rats infected with S. aureus after intratracheal administration: A Novel antimicrobial and Antibiofilm strategy” at 8th International Annual Conference organized by South Asian Chapter of American College of Clinical Pharmacology (SAC-ACCP) 2015
2) Dr. ArunSanghai Prize (Second prize- Preclinical Category) for Oral Presentation on “Pressure Sensitive Capsules for Targeted Delivery to Colon: Proof of Concept” at 8th International Annual Conference organized by South Asian Chapter of American College of Clinical Pharmacology (SAC-ACCP). 2015
3) First prize for presentation of research project entitled “Ligand Targeted Delivery Systems for Liver Cancer Therapeutics” at Avishkar - 8th Maharashtra State Inter-University Research Convention. 2014
4) Association of Pharmaceutical Teachers of India (APTI) Dr. (Mrs.) Manjushree Pal Best Researcher National Award 2013 2013
5) Prof M. L. Khorana best research paper award for paper “M. P. Jadhav, M. S. Nagarsenker, R. V. Gaikwad, A. Samad, N. A. Kshirsagar, Formulation and Evaluation of Long Circulating Liposomal Amphotericin B: A Scinti-kinetic Study using Tc in BALB/C Mice. Indian journal of pharmaceutical sciences 2011;73(1):57-64”. 2013
6) Amrut Mody Research Fund, Distinguished Researcher National Award 2012
7) Prof. (Mrs.) M. R. Baichwal Visiting fellow in Pharm Sci. and Technology for UICT 2005-2006

Government Projects (Last Five Years):

Sr no. Project Title Funding agency
1) Lipid based nanocarriers for delivery of poorly soluble drugs. ICMR-BMBF
2) Advance Drug Delivery System: Development and Evaluation of liposomal drug delivery system for treatment of infectious diseases and disorders CSIR
3) Design and Evaluation of novel polymer-lipid hybrid nanocarriers for improved systemic delivery of siRNA DBT
4) Bone targeted nano drug delivery systems for treatment of osteodegenerative disease in improvement of women health DST
5) NanoparticulateEnzybiotic approach for improved pulmonary delivery of antibiotics ICMR
6) Novel Lipids in Biocompatible Nanosystems for Targeting Hepatic Diseases and Disorders. Lady Tata Memorial Trust

Industrial Projects (Last Five Years):

Sr. no. Project Title Industry
1) Biovailability enhancement of Class II drugs using Gelucires. Gattefosse India Pvt Ltd
2) Characterization of PBLs Nanosystems Panacea Biotech Ltd

Recent Publications:

Sr no. Paper Title Journal Year
1) LeciPlex, invasomes, and liposomes: A skin penetration study International Journal of Pharmaceutics 2015
2) Cholesterol anchored arabinogalactan for asialoglycoprotein receptor targeting: synthesis, characterization, and proof of concept of hepatospecific delivery. Carbohydrate research 2015
3) Compritol® 888ATO a lipid excipient for sustained release of highly water soluble active: Formulation, Scale-up and IVIVC study. Current Drug Delivery Current Drug Delivery 2015
4) Duloxetine HCl Lipid Nanoparticles: Preparation, Characterization, and Dosage Form Design AAPS PharSciTech 2013
5) Lecithin-based novel cationic nanocarriers (Leciplex) II: improving therapeutic efficacy of quercetin on oral administration Molecular Pharmaceutics 2011
6) Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances Nanomedicine 2010

Recent Patents:(ALL)

Sr no. Patent Title Patent Number
1) A process for preparing oral composition of ondansetron 206316
2) Gastroretentive systems and novel pharmaceutical compositions thereof 234801
3) Novel compositions for improved delivery of drugs with poor aqueous solubility 269000
4) Pharmaceutical Composition Comprising Solid Dispersion of BCS Class II Drugs with Gelucires. Application no. 1874/MUM/2014

Key Research Area

»

Fabrication and characterization of nanocarriers like liposomes, lipid particulates, nanosuspensions, Self nanoemulsifying drug delivery systems in the area of Oncology, pain management, antivirals.

»

Design and development controlled release and targeted delivery systems..

»

Investigations on three trademark systems LeciPlex®, Lecithmer® and GeluPearl®.

»

Evaluation of role of excipients in design of dosage form.

»

Delivery systems for siRNA for improved therapy.

Go to TOP

 

Name of the Faculty: Dr. (Mrs) Mala D. Menon

Designation: Professor in Pharmaceutics

Email: maladm@bcpindia.org

Teaching Fields : Pharmaceutics, Novel drug delivery systems, Cosmeticology, Immunology, Microbiology, Polymers.





Educational Qualifications:

Sr no. Degree University Year of Passing
1) Ph. D. (Tech) Mumbai University 1994
2) M. Pharm. Mumbai University 1983
3) B. Pharm. Mumbai University 1980

Awards and Fellowships:

Sr no. Award/Fellowship Year of Receipt
1) First prize in Poster Presentation titled ‘Fabrication and Evaluation of Apparatus for Simultaneous Dissolution and Permeation studies-A feasibility study’ at Disso Asia 2014 conference organised by SPDS in Mumbai May 2014
2) Second prize in Poster Presentation titled ‘Development of In Vitro Release Method for Generic Parenteral Suspension Using USP Type IV Dissolution Apparatus’ at Disso Asia 2014 conference organised by SPDS in Mumbai May 2014
3) Received third prize for poster presentation titled “ Evaluation of 99m Tc microspheres for lung deposition using gamma camera” at 43rd Annual Conference of Society of Nuclear Medicine, India at Chennai December 2011
4) Received second prize for poster presentation titled “feasibility studies for development of inhalation systems for improved therapy of tuberculosis” at Nasal & Pulmonary Symposium, organized by Indian Pharmaceutical Association at Mumbai November 2011
5) Received second prize for poster presentation titled “feasibility studies for development of inhalation systems for improved therapy of tuberculosis” at Nasal & Pulmonary Symposium, organized by Indian Pharmaceutical Association at Mumbai February 2011
6) Second prize for poster titled-Sustained Release Budesonide Liposomes: Lung Deposition and Efficacy Evaluation, Symposium on Advances in Pulmonary and nasal drug delivery, Mumbai. October 2007
7) First prize for poster titled-Poloxamer Coated Fluticasone Propionate Microparticles for Pulmonary Delivery – In Vivo Lung Deposition and Efficacy Studies. Symposium on Advances in Pulmonary and nasal drug delivery, Mumbai October 2007
8) First prize – oral presentation titled “Pulmonary Deposition Study of Radiolabelled Budesonide Liposomes in Animals by Gamma Scintigraphy”, Symposium of Indo-American Society of Nuclear Medicine in 38th Annual Conference of Society of Nuclear Medicine, India December 2006
7) Third prize for poster “Aerosolization Studies on Poloxamer Encapsulated Fluticasone Propionate, using Surface Modified Carrier” in the session of Pharmaceutical Technology at 58th Indian Pharmaceutical Congress held at Bombay Exhibition Centre, Mumbai December 2006

Recent Publications: (Best five in last five years)

Sr no. Paper Title Journal
1) Three-way, three-period, crossover bioequivalence study of single oral dose of three brands of 300 mg phenytoin sodium tablets marketed in india, on healthy indian human volunteers Journal of Pharmacology & Pharmacotherapeutics, 2013, 4, 243.
2) Induction of Mucosal Immunization Against Streptococcus mutans Via Intranasal Administration--A Feasibility Study RDD Europe 2013 (2013), Vol 2, 257 - 260
3) Nose-to-Brain Delivery of Chlorpromazine Hydrochloride - A Feasibility Study RDD Europe 2013 (2013) , Vol 2, 261 - 266
4) Nanoparticle Based DPI Formulation for Active Targeting of Etoposide in Lung Cancer Respiratory Drug Delivery 2012, 2012, 427-432
5) Inhalational system for etoposide liposomes: Formulation development and in vitro deposition Indian journal of pharmaceutical sciences, 2011, 73, 656.s
6) Book Chapter: Aerosolised Nanoparticle based Approaches for Treatment of Lung Cancer Volume on “Drug Delivery,” multi-volume book series on “Recent Developments in Biotechnology” published by Studium Press LLC, USA. Editor- Professor Bhupinder Singh Bhoop (In press)

Recent Patents:(ALL)

Sr no. Patent Title Patent Number
1) Composition For Prolonged Release Of Drugs 1668/MUM/2009
2) Stable Enzyme in-situ gelling system E2/124/2012/MUM
3) Nasal formulation of Chlorpromazine” based on nose to brain delivery of chlorpromazine 1986/MUM/2013
4) Apparatus for the determination of dissolution and permeation of drugs” 518/MUM/2014

Recent Presentations: (Best five in last five years)

Sr no. Presentation Title (Best Five in last five years) Conference Details
1) Formulation and evaluation of Oral Nanosuspension of Cefixime AAPS Annual Meeting and Exposition, November 2013 San Antonio, Texas, USA. American Association of Pharmaceutical Scientists.
2) Induction of Mucosal Immunization Against Streptococcus mutants Via Intranasal Administration –A Feasibility Study Respiratory Drug Delivery Europe 2013. 21-23 may 2013 Germany.
3) Nose-to-Brain Delivery of Chlorpromazine Hydrochloride –A Feasibility Study Respiratory Drug Delivery Europe 2013, 21-23 may 2013, Germany,
4) In-vitro Release Characterization of Sustained Release Chitosan based in- situ gelling Systems for Treatment of Bovine Mastitis. Disso India 2013, 3 and 4 May 2013, Mumbai, India, organized by SPDS.
5) Development of In Vitro Release Method for Generic Parenteral Suspension Using USP Type IV Dissolution Apparatus Disso Asia 2014, 5 and 6 May 2014, Mumbai, India, organized by SPDS.

Recent Presentations: (Best five in last five years)

Sr no. Title Industry/institute
1) Dissolution method development using USP type IV apparatus Getz Pharma Research,
2) Dissolution method development using USP type IV apparatus. Cipla Ltd,
3) Inhalation & Nasal vaccine delivery systems Serum Institute Pune
4) Analysis of novel antitubercular formulations Piramal life sciences
5) Development of DPI formulation for COPD Inhalation products consultancy

Consultancy Services: (in last five years)

Sr no. Title Industry/institute
1) Use of USP type IV dissolution testing apparatus USV Ltd (2010-12)
2) Three way, three period, cross over bioequivalence study of single oral dose of three brands of 300 mg Phenytoin sodium tablets marketed in India, on healthy volunteers Abbott India Ltd (2010-11)
3) Testing of probiotic samples Hanschen Probiotics (2008- 11)
4) Development of Dissolution method by USP Type IV apparatus for depot injection Famy Care (2012)
5) Dissolution study of tablets using USP Type IV apparatus Glenmark Ltd (2012)
6) Development of dissolution method by USP Type IV apparatus for ophthalmic suspension Getz Pharma Research (2012)
7) Dissolution studies on injectable suspension using USP Type IV apparatus Cipla Ltd (2013)

Research Area and interest:

Design and development of novel drug delivery systems – in situ gelling systems, ophthalmic drug delivery, pulmonary drug delivery, liposomal systems, nanoparticulate systems.

Expertise and instrumental/research facilities you can provide to interested parties: Instrumental-

1.

SOTAX-USP Type IV Dissolution Apparatus- Method development and feasibility studies for various types of dosage forms.

2.

Biocryos Lyophilizer-trial batches.

3.

3) Copley’s Cascade Impactor and Twin stage Impinger – for evaluation of Fine particle fraction (FPF), Mass mean aerodynamic diameter (MMAD) (aerosolization properties) of inhalation systems, as per pharmacopoeial methods.

4.

Permeabilty studies-Franz diffusion cells


Expertise-

1.

Preformulation studies and Development of dosage forms-conventional & novel drug delivery systems

2.

Inhalation and nasal delivery systems-development, comparative studies-formulations and devices, including animal evaluations.

3.

Probiotic formulations-assessment , formulation development

4.

Novel mucosal vaccine delivery – formulation development and immunogenicity evaluations

5.

Enzyme delivery systems-development and assessment.

6.

Bioavailability & Bioequivalence studies-in vitro and in vivo.

Go to TOP

 

Name of the Faculty: Dr. (Mrs) Ujwala A. Shinde

Designation: Asst. Professor in Pharmaceutics

Email: ujwalas@bcpindia.org

Teaching Fields : Pharmaceutics, Cosmeticology, Dispensing Pharmacy, Hospital Pharmacy, Physical Pharmacy, Pharmaceutical Engineering.





Educational Qualifications:

Sr no. Degree University Year of Passing
1) Ph. D. (Tech) Mumbai University 2005
2) M. Pharm. Mumbai University 1992
3) B. Pharm. Mumbai University 1990

Awards and Fellowships:

Sr no. Paper Title Journal / Year / Vol / Page
1) Serratiopeptidase Niosomal Gel with Potential in Topical Delivery. Journal of Pharmaceutics published online , vol. 2014, Article ID 382959, 9 pages, 2014. doi:10.1155/2014/382959.
2) Design and characterization of chitosan-alginate microspheres for ocular delivery of azelastine Pharmaceutical development and technology, 2014, 19, 813-823.
3) Development of dorzolamide loaded 6-o-carboxymethyl chitosan nanoparticles for open angle glaucoma Journal of drug delivery, 2013, 562727.
4) EudragitRL100 based microspheres for ocular administration of azelastineh ydrochloride Journal of microencapsulation, 2012, 29, 511-519.
5) Design and evaluation of microemulsion gel system of nadifloxacin Indian journal of pharmaceutical sciences, 2012, 74, 237-247.
6) Chitosan nanoparticles for controlled delivery of brimonidine tartrate to the ocular membrane Die Pharmazie, 2011, 66, 594-599.
7) Microencapsulation of Eugenol by GelatinSodium Alginate Complex Coacervation Indian. J. Pharm.Sci, 2011, 73(3):311-315.

Recent Presentations: (Best Five in last five years)

Sr no. Presentation Title(Best Five in last five years) Conference Details
1) Chitosan Nanoparticles of Levofloxacin-Flurbiprofen for Bacteial Conjuntivitis. Avishkar 2013-14. Jan 2014, Mumbai Mumbai University.
2) Development of Dorzolamide loaded 6-O-carboxymethyl Chitosan Nanoparticles for Open Angle Galucoma. Avishkar 2013-14, Jan 2014, Mumbai, Mumbai University.
3) Evaluation of Dissolution Efficiency of Erlotinib Solid Dispersions. SPDS Disso India 2013, International Annual Symposium. 3-4 May 2013 Mumbai, SOTAX and Bombay College of Pharmacy.
4) Lipid Nanoparticles of Albendazole: Formulation and In-Vivo efficacy evaluation in the treatment of ToxocaraCanis larva migrans infection. International Symposium on "Drug Discovery for Infectious Diseases and Cancer" 16-17 Jan 2013 Mumbai Institute of Chemical Technology.
5) Mucoadhesive Microemulsion of Azelastine Hydrochloride And Mometasone Furoate for Allergic Rhinitis 5th Symposium on Nasal and Pulmonary drug Delivery, Mumbai , 17-18 Sept. 2011.


Research Area and interest:

Novel Drug Delivery Systems:

»

Polymeric nanoparticles for ocular route

»

Niosomes for topical and parenteral route

»

Liposomes for nasal route

»

Microemulsions for topical route

»

Solid lipid nanoparticles for parenteral and pulmonary route


Expertise and instrumental/research facilities you can provide to interested parties:

»

Facility for measurement of particle size and zeta potential on Zetasizer Nano ZS (Malvern Instruments, UK)

»

Facility for analysis on HPLC isocratic system with UV detector (Jasco, Japan)

Go to TOP


 

Name of the Faculty: Dr. (Mrs.) Namita D. Desai

Designation: Asst. Professor in Pharmaceutics

Email: namitadesai@bcpindia.org

Teaching Fields : Pharmaceutics, dispensing pharmacy, physical pharmacy, hospital pharmacy, biopharmaceutics.





Educational Qualifications:

Sr no. Degree University Year of Passing
1) Ph. D. (Tech) Mumbai University 2006
2) M. Pharm. Mumbai University 2001
3) B. Pharm. Mumbai University 1999

Recent Patents/Trademarks/Copyrights:(ALL)

Sr no. Patent Title Patent Number
1) MELTLETS (Trade Mark) Trademark Registry, Feb. 2004

Recent Presentations: (Best Five in last five years)

Sr no. Presentation Title(Best Five in last five years) Conference Details
1) Formulation and in vitro release of solid self microemulsifying formulation of Meloxicam, SPDS Disso Asia 2014, International Symposium held in Mumbai, India, May 2014.

Recent Presentations: (Best Five in last five years)

Sr no. Presentation Title(Best Five in last five years) Conference Details
1) Formulation and in vitro release of solid self microemulsifying formulation of Meloxicam, SPDS Disso Asia 2014, International Symposium held in Mumbai, India, May 2014.

Consultancy Services: (in last five years)

Sr. No. Title Industry/institute
1) Confidential Bajaj Health care

Research Area and interest:

»

Design and development of novel drug delivery systems - oral and transdermal and platform technologies, orally disintegrating compositions.

Go to TOP

 

Name of the Faculty: Dr. Shruti Jayesh Parmar

Designation: Asst. Professor in Pharmaceutics

Email: : shrutiparmar@bcpindia.org

Teaching Fields : Pharmaceutics, physical pharmacy, dispensing pharmacy, drug store management





Educational Qualifications:

Sr no. Degree University Year of Passing
1) Ph. D. (Tech) Mumbai University 2008
2) M. Pharm. Mumbai University 2002
3) B. Pharm. Mumbai University 1998

Recent Patents/Trademarks/Copyrights:(ALL)

Sr no. Patent Title Patent Number
1) Herbal Contraceptive formulations Indian Patent 57/MUM/2005,
2) Herbal Contraceptive formulations Indian Patent 58/MUM/2005,
3) Herbal Contraceptive formulations PCT WO/2006/087733
4) Herbal Contraceptive formulations USPTO Application No. 20080152713,
5) NanoNeem (Trade Mark) and HerbOshield (Trade Mark) Trade Mark Registry,

Research Area and interest:

»

Design and development of novel drug delivery systems, mucoadhesive drug delivery systems, nanoemulsions based systems, herbal drug delivery systems.

Go to TOP

 

Name of the Faculty: Miss-Shubhangi Y. Aher

Designation: Asst. Professor inPharmaceutics

Email: :shubhangi@bcpindia.org

Teaching Fields : Pharmaceutics, physical pharmacy, dispensing pharmacy, Microbiology, Pharmaceutical engineering





Educational Qualifications:

Sr no. Degree University Year of Passing
1) M. Pharm. Pune University 2009
2) B. Pharm. North Maharashtra University,Jalgaon 2006

Research Area and interest:

»

Enhancement of solubility and dissolution of poorly water soluble drug, Design and development of novel drug delivery systems, mucoadhesive drug delivery systems, nanoemulsions based systems, herbal drug delivery systems.

Go to TOP
© Copyright. Bombay College of Pharmacy. All rights reserved. Site created and maintained by: K S Softech